| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/24/2008 | CN101269003A Oral preparation containing roxithromycin, preparation method and application thereof |
| 09/24/2008 | CN101269002A Oral preparation containing penicillin G, preparation method and application thereof |
| 09/24/2008 | CN101269000A Oral preparation containing cefa-iskia, preparation method and application thereof |
| 09/24/2008 | CN100420754C Method for preparing anthracene Ensamu bacterial |
| 09/24/2008 | CN100420689C Porphyrin derivate with macrosubstituent, preparation process thereof and use as small molecule antioxidant |
| 09/24/2008 | CN100420682C Separating preparation process of salvianolic acid B |
| 09/24/2008 | CN100420679C Novel compound, bacteria strain and method for producing novel compound using the strain |
| 09/24/2008 | CN100420484C Human lysozyme suppository, preparation method and application |
| 09/24/2008 | CN100420482C Method for short-term and long-term drug dosimetry |
| 09/24/2008 | CN100420458C Externally applied Chinese traditional medicine formulation and its preparing method |
| 09/24/2008 | CN100420456C Compounded Radix Bupleuri enema preparation and preparing method |
| 09/24/2008 | CN100420443C Nucleotide analog composition and synthesis method |
| 09/23/2008 | US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 09/23/2008 | US7427658 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor |
| 09/23/2008 | US7427598 Post-natal administration of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory |
| 09/23/2008 | US7427592 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia |
| 09/23/2008 | US7427495 Enhancing or inhibiting apoptosis |
| 09/23/2008 | US7427397 Vitamin B12 supplement comprising Propionibacterium jensenii 702 together with a delivery agent; tuberculosis |
| 09/23/2008 | US7427394 Delivering labile agents; buffering effect; transfecting nucleic acids; nontoxic |
| 09/23/2008 | CA2582676A1 Building structure and components thereof |
| 09/23/2008 | CA2483875C 6,11 bicyclic erythromycin derivatives |
| 09/23/2008 | CA2432872C Pyrazole compounds useful as protein kinase inhibitors |
| 09/23/2008 | CA2420952C A novel antifungal molecule 2-(3,4-dimethyl-2,5-dihydro-1h-pyrrol-2-yl)-1-methylethyl pentanoate |
| 09/23/2008 | CA2418313C Piperidine derivatives and agent comprising the derivative as active ingredient |
| 09/23/2008 | CA2378390C Tixocortol pivalate suspension, collutorium based on it and packaging containing it |
| 09/23/2008 | CA2352915C Pharmaceutical compositions containing mupirocin |
| 09/23/2008 | CA2310055C New urethanes, the thio and dithio analogues thereof,the salts thereof, pharmaceutical compositions containing these compounds and their use as well as process for preparing them |
| 09/23/2008 | CA2157047C Aureobasidins |
| 09/18/2008 | WO2008112863A1 Compounds for the treatment of hepatitis c |
| 09/18/2008 | WO2008112851A1 Cyclopropyl fused indolobenzazepine hcv inhibitors |
| 09/18/2008 | WO2008112848A1 Compounds for the treatment of hepatitis c |
| 09/18/2008 | WO2008112841A1 Compounds for the treatment of hepatitis c |
| 09/18/2008 | WO2008112473A1 Compounds for the treatment of hepatitis c |
| 09/18/2008 | WO2008112289A2 Oligomer-protease inhibitor conjugates |
| 09/18/2008 | WO2008112199A1 Method for inhibiting topoisomerase ii |
| 09/18/2008 | WO2008111978A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 09/18/2008 | WO2008111943A2 Secreted campylobacter flagella coregulated proteins as immunogens |
| 09/18/2008 | WO2008111908A1 Five- and six-membered conformationally locked 2',4'- carbocyclic ribo-thymidines for the treatment of infections and cancer |
| 09/18/2008 | WO2008111532A1 Lyophilized preparation comprising influenza vaccine, and method for preparation thereof |
| 09/18/2008 | WO2008111430A1 METHOD FOR PRODUCING γδT CELL POPULATION |
| 09/18/2008 | WO2008111429A1 Disinfectant |
| 09/18/2008 | WO2008111384A1 Epithelium improving agent |
| 09/18/2008 | WO2008110840A1 Beneficial effects of bacteriophage treatments |
| 09/18/2008 | WO2008110508A1 Pyrrolo-pyridine derivatives for the treatment of disorders associated with inappropriate ikk1 activity |
| 09/18/2008 | WO2008110351A2 Use of (r) and (s)-2-aryl-propionic acid derivatives as antiseptic agents |
| 09/18/2008 | WO2008110080A1 Medical composition containing cyclodextrin inclusion compound of cefixime and its preparation method |
| 09/18/2008 | WO2008110079A1 Medical composition containing cyclodextrin inclusion compound of cefdinir and its preparation method |
| 09/18/2008 | WO2008110056A1 A vaccine for porcine reproductive and respiratory syndrome, a preparion method and use thereof |
| 09/18/2008 | WO2008110035A1 A pharmaceutical composition containing inclusion compound of cyclodextrin and adefovir dipivoxil and preparative method thereof |
| 09/18/2008 | WO2008109972A1 Homeopathic medicament useful for immunomodulation |
| 09/18/2008 | WO2008109958A1 Methods for evaluation of oral vaccines |
| 09/18/2008 | WO2008109943A1 Phenyl amino pyrimidine compounds and uses thereof |
| 09/18/2008 | WO2008087441A3 An influenza prevention and treatment composition |
| 09/18/2008 | WO2008059014A3 Antituberculosis agents with alkylidene or alkyl side chain |
| 09/18/2008 | WO2008045920A3 Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses |
| 09/18/2008 | WO2007121124A3 Hcv inhibitors comprising beta amino acids and their uses |
| 09/18/2008 | WO2007104933A8 Chemical compounds |
| 09/18/2008 | US20080227954 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders |
| 09/18/2008 | US20080227869 Substituted nitrobenzene derivatives as pharmaceutical and other uses thereof |
| 09/18/2008 | US20080227833 Selective inhibitors of MMP-9 and/or MMP12; antiinflammatory agents for multiple sclerosis and fibrosis; 3R-[2,2-Dimethyl-1 S-(5-phenyl-[1,2,4]oxadiazol-3-yl)-propylcarbamoyl]-2S-hydroxy-5-methyl-hexanohydroxamic acid; bone resorption, metastases, rheumatoid arthritis, Crohn's disease |
| 09/18/2008 | US20080227828 Aryl Ureas With Angiogenisis Inhibiting Activity |
| 09/18/2008 | US20080227808 5-{3-[3-Bromo-5-methylsulfanyl-2-(2-pyridin-3-yl-ethoxy)-benzylamino]-propylamino}-4H-thieno[3,2-b]pyridine-7-one; anti-Clostridium difficile agents |
| 09/18/2008 | US20080227798 inhibiting dipeptidyl peptidases; diabetes mellitus |
| 09/18/2008 | US20080227777 Pyrazolopyridine derivatives as inhibitors of beta-Adrenergic Receptor Kinase 1 |
| 09/18/2008 | US20080227775 Quinoline Derivatives as Antibacterial Agents |
| 09/18/2008 | US20080227774 5,5-disubstituted-indolizinone compounds |
| 09/18/2008 | US20080227769 Compounds for the Treatment of Hepatitis C |
| 09/18/2008 | US20080227768 treating a bacterial infection selected from the group consisting of Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli and Pseudomonas aeruginosa |
| 09/18/2008 | US20080227754 Phosphoramidate linkages; retroviral or hepadnaviral therapy; tissue targeted therapy; HIV/aquired immunodeficiency syndrome; antitumor agents; improved bioavailability |
| 09/18/2008 | US20080227751 Method and agent for the prevention, inhibition and treatment of sepsis |
| 09/18/2008 | US20080227744 Benzofuran derived hiv protease inhibitors |
| 09/18/2008 | US20080227743 Amantadine or rimantadine, and ribavirin or viramidine, and optionally a neuraminidase inhibitor such as oseltamivir, zanamivir, or peramivir |
| 09/18/2008 | US20080227732 Treatment and Control of Severe Infections Including Cystic Fibrosis |
| 09/18/2008 | US20080227729 Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds |
| 09/18/2008 | US20080227724 3-(alkanoyl or alkenoyl)amino-caprolactams; autoimmune diseases, asthma, osteoporosis, transplant rejection, psoriasis, Alzheimer's Disease, Multiple sclerosis, ALS; antitumor, antiarthritic, antifibrotic, and antiscarring agents |
| 09/18/2008 | US20080227706 Polypeptides and polynucleotides; genetic engineering; medical diagnosis; treatment of infection causes sepsis, meningitis, pneumonia, cellulitis, osteomyelitis, septic arthritis, endocarditis or epiglottis; bacterial protein antigen vaccine |
| 09/18/2008 | US20080227697 Bacterial protein phosphoinositide probes and effectors |
| 09/18/2008 | US20080227204 Nutrient broth comprising fibronectin and CD-3 specific antibody for use as inductive source for propagation of natural killer cells |
| 09/18/2008 | US20080226760 Antimicrobial composition and use thereof |
| 09/18/2008 | US20080226695 Water degradation; controlled drying; self-supporting edible film; uniform distribution; mixing water soluble polymer with water and active material; deaeration |
| 09/18/2008 | US20080226683 Potentiating clinoptilolite via saline wash and drying; medicant filler materials; removing metals, nitrates and toxins from organ tissues |
| 09/18/2008 | US20080226680 Applying flavored therapeutic to animal muzzle and allowing licking action to deliver medicine to nasal and/or oral mucosa |
| 09/18/2008 | US20080226678 Generating lymphocytes immune response; vector gene expression ; induction lymphocyte response against antigen using adenovirus vector; antiulcer agents; inflammatory bowel disorders; autoimmune diseases; anticancer agenst |
| 09/18/2008 | US20080226677 Recombinant virus vector for gene transfer into lymphoid cells |
| 09/18/2008 | US20080226675 Supplying genes to human cells; gene expression blocks; mutant lentivirus vectors; prevention, therapy aids |
| 09/18/2008 | US20080226672 Adjuvant Systems and Vaccines |
| 09/18/2008 | US20080226671 Deactivation or attenuation Mycoplasma vaccine for cattle; side effect reduction; respiratory system disorders ; mammary disorders; joint, eye, ear infections |
| 09/18/2008 | US20080226670 Prevent disease caused by Bordetella; distemper; hepatitis; adenovirus; enteritis; coronavirus; parvirus;leptospira |
| 09/18/2008 | US20080226669 Protein which expresses open reading frame of circoviruses |
| 09/18/2008 | US20080226666 Immunogenic polypeptide for protecting pigs against viral infection or postweaning multisystemic wasting syndrome |
| 09/18/2008 | US20080226661 Using immunoaffinity recognition to identify phage clones expressing mycoplasma peptides; developing vaccines for prevention and treatment of contagious bovine pleuropneumonia |
| 09/18/2008 | US20080226651 Envelope protein specific immunoglobulin for use in treatment and prevention human immunodeficieny virus infection |
| 09/18/2008 | US20080226647 Using interferon gamma receptor 1 (IFNGR1) specific immunoglobulin for diagnosis, prevention and treatment of myxovirus infection |
| 09/18/2008 | US20080226646 Use of biomolecular targets in the treatment and visualization of tumors |
| 09/18/2008 | US20080226641 Mixture comprising group B streptococcal peptide for use in generating vaccine and immunoglobulins for diagnosis, prevention and treatment of urinary tract infections |
| 09/18/2008 | US20080226640 Mixture comprising serum complement system protein (INSP162) use in preparation of vaccines and antibodies for treatment and prevention of infcetion, cell proliferative, skin, neurodegenerative, bone, inflammatory, respiratory system and autoimmune disorders |
| 09/18/2008 | US20080226637 Hemophilus polypeptide for generating immunoglobulins and vaccines for use in prevention and treatment of bacterial infection |
| 09/18/2008 | US20080226618 Hydantoin derivatives useful as antibacterial agents |
| 09/18/2008 | US20080226605 Methods and Compositions Facilitating Entry of Compounds Into Cells |
| 09/18/2008 | US20080226598 Dendritc specific RNA viral plasmid comprising nucleotide sequences coding tumor associated for use in developing cancer vaccine; genetic vaccines |